journal article·2011-12-01

A fibroblast/macrophage co-culture model to evaluate the biocompatibility of an electrospun Dextran/PLGA scaffold and its potential to induce inflammatory responses

Hui Pan, Hongliang Jiang, Sarah Kantharia, Weiliam Chen

Biomedical Materials· Volume 6· Issue 6
Publisher page

Abstract

Fibroblasts and macrophages are the two major types of cells responding to implanted biomaterials. They play crucial roles in inflammatory responses, host-material interactions and tissue remodeling. However, the synergistic interactions of these two cell types with biomaterials are not fully understood. In this investigation, an in vitro fibroblast/macrophage co-culture system was utilized to examine the biocompatibility and the potential to induce inflammatory responses of an electrospun Dextran/PLGA scaffold. The scaffold did not affect the morphologies, attachments, proliferations and viabilities of both the fibroblasts and macrophages, cultured separately or together. Moreover, it only activated a small subset of the macrophages implicating a low potential to induce either severe acute or chronic inflammatory response. Additionally, fibroblasts played a role in prolonging macrophage activation in the presence of the scaffolds. Using antibody arrays, IL-10, SDF-1, MIP-1 gamma and RANTES were found to be up-regulated when the cells were incubated with the scaffolds. The results of subdermal implantation of the Dextran/PLGA scaffolds confirmed its biocompatibility and low inflammatory potential.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Nerve injury and regeneration

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (49)

Show source-provided references
1. Xia J T · Biomed. Mater. · 2006 · 1 · 110.1088/1748-6041/1/1/001 ↗
2. Ratner B D · Biomaterials Science: An Introduction to Materials in Medicine · 2004
3. 10.1016/j.jconrel.2005.09.01510.1016/j.jconrel.2005.09.015 ↗
4. 10.1016/j.biomaterials.2006.01.03210.1016/j.biomaterials.2006.01.032 ↗
5. 10.1016/j.biomaterials.2006.08.04110.1016/j.biomaterials.2006.08.041 ↗
6. Jones L C · Biomed. Sci. Instrum. · 2006 · 42 · 223
7. 10.1002/jbm.1028610.1002/jbm.10286 ↗
8. Xia Z · J. Biomed. Mater. Res · 2006 · 79 · 58210.1002/jbm.a.30853 ↗
9. 10.1016/j.biomaterials.2007.12.00510.1016/j.biomaterials.2007.12.005 ↗
10. 10.1021/bm034345w10.1021/bm034345w ↗
11. 10.1189/jlb.040628710.1189/jlb.0406287 ↗
12. Gwinn M R · J. Toxicol. Environ. Health · 2006 · 9 · 2710.1080/15287390500196081 ↗
13. 10.1002/jgm.72410.1002/jgm.724 ↗
14. 10.1016/S0169-409X(00)00054-510.1016/S0169-409X(00)00054-5 ↗
15. 10.1002/(SICI)1097-0215(19970611)71:6<956::AID-IJC8>3.0.CO;2-X10.1002/(SICI)1097-0215(19970611)71:6<956::AID-IJC8>3.0.CO;2-X ↗
16. 10.1097/00006534-199710000-0003510.1097/00006534-199710000-00035 ↗
17. 10.2307/343424210.2307/3434242 ↗
18. 10.1016/j.biomaterials.2005.05.07910.1016/j.biomaterials.2005.05.079 ↗
19. 10.1080/1073119050028990910.1080/10731190500289909 ↗
20. Evonuk E · Am. J. Physiol. · 1967 · 212 · 51410.1152/ajplegacy.1967.212.2.514 ↗
21. Johnston R B · Adv. Exp. Med. Biol. · 1988 · 239 · 6310.1007/978-1-4757-5421-6_7 ↗
22. 10.1146/annurev.iy.02.040184.00143510.1146/annurev.iy.02.040184.001435 ↗
23. 10.1515/bchm3.1990.371.2.102110.1515/bchm3.1990.371.2.1021 ↗
24. 10.1385/IR:26:1-3:09510.1385/IR:26:1-3:095 ↗
25. 10.1016/j.biomaterials.2003.12.00410.1016/j.biomaterials.2003.12.004 ↗
26. 10.1146/annurev.bi.63.070194.00113510.1146/annurev.bi.63.070194.001135 ↗
27. 10.1073/pnas.023708310010.1073/pnas.0237083100 ↗
28. Tomasi A · Free Radicals, Nitric Oxide and Inflammation · 2003 · 264
29. Schaffer M R · J. Immunol. · 1997 · 158 · 237510.4049/jimmunol.158.5.2375 ↗
30. 10.1002/(SICI)1097-4636(199611)32:3<355::AID-JBM8>3.0.CO;2-R10.1002/(SICI)1097-4636(199611)32:3<355::AID-JBM8>3.0.CO;2-R ↗
31. 10.1016/S0142-9612(97)00058-610.1016/S0142-9612(97)00058-6 ↗
32. Thorns M · Biomed. Sci. Instrum. · 2001 · 37 · 287
33. 10.1006/bbrc.2000.260210.1006/bbrc.2000.2602 ↗
34. Ross J A · The Macrophage · 2002
35. 10.1016/j.biomaterials.2010.04.02210.1016/j.biomaterials.2010.04.022 ↗
36. 10.1023/A:100895232978810.1023/A:1008952329788 ↗
37. 10.1097/00062752-200001000-0000810.1097/00062752-200001000-00008 ↗
38. 10.1016/S0002-9440(10)63265-810.1016/S0002-9440(10)63265-8 ↗
39. 10.1146/annurev.immunol.23.021704.11581610.1146/annurev.immunol.23.021704.115816 ↗
40. Sorg C · Chest · 1991 · 100 · 17310.1378/chest.100.3_Supplement.173S ↗
41. 10.1023/A:101855232680810.1023/A:1018552326808 ↗
42. 10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H ↗
43. 10.1074/jbc.M60522920010.1074/jbc.M605229200 ↗
44. Taub D D · Ther. Immunol. · 1994 · 1 · 229
45. Fedyk E R · J. Immunol. · 2001 · 166 · 574910.4049/jimmunol.166.9.5749 ↗
46. 10.1038/jid.2008.40510.1038/jid.2008.405 ↗
47. 10.2332/allergolint.10-OA-020710.2332/allergolint.10-OA-0207 ↗
48. 10.1042/0264-6021:347026510.1042/0264-6021:3470265 ↗
49. 10.1002/(SICI)1097-4636(20000605)50:3<365::AID-JBM10>3.0.CO;2-X10.1002/(SICI)1097-4636(20000605)50:3<365::AID-JBM10>3.0.CO;2-X ↗